Chronic migraine (cm): prevalence, headache-related disability and sociodemographic factors in the us population: results from the american migraine prevalence and prevention (ampp) study

被引：0
|
作者：
Buse, D. C. [1 ,2 ]
Reed, M. L. [3 ]
Manack, A. N. [4 ]
Fanning, K. [3 ]
Serrano, D. [3 ]
Turkel, C. C. [5 ]
Lipton, R. B. [1 ,2 ]
机构：
[1] Albert Einstein Coll Med, Neurol, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Headache, Bronx, NY 10467 USA
[3] Vedanta Res, Hlth Res, Chapel Hill, NC USA
[4] Allergan Pharmaceut Inc, Epidemiol & Populat Hlth, Irvine, CA USA
[5] Allergan Pharmaceut Inc, Res & Dev, Irvine, CA USA
来源：
CEPHALALGIA | 2011年 / 31卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PS1-23
引用
收藏
页码：29 / 30
页数：2
相关论文
共 50 条
  • [31] Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study
    Munakata, Julie
    Hazard, Elisabeth
    Serrano, Daniel
    Klingman, David
    Rupnow, Marcia F. T.
    Tierce, Jonothan
    Reed, Michael
    Lipton, Richard B.
    HEADACHE, 2009, 49 (04): : 498 - 508
  • [32] Acute Treatment Optimization in Episodic and Chronic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
    Serrano, Daniel
    Buse, Dawn C.
    Adams, Aubrey Manack
    Reed, Michael L.
    Lipton, Richard B.
    HEADACHE, 2015, 55 (04): : 502 - 518
  • [33] Gaps in the Acute Treatment of Episodic and Chronic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
    Lipton, Richard
    Manack, Aubrey
    Serrano, Daniel
    Buse, Dawn
    NEUROLOGY, 2013, 80
  • [34] Nocturnal Headache and Sleep Disturbance in Episodic Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study
    Reed, M. L.
    Fanning, K. M.
    Buse, D. C.
    Lipton, R. B.
    HEADACHE, 2012, 52 (05): : 889 - 890
  • [35] Age-specific estimates of lost time due to headache in chronic migraine and episodic migraine: results from the American migraine prevalence and prevention (AMPP) study
    Buse, D. C.
    Manack, A.
    Serrano, D.
    Turkel, C. C.
    Lipton, R. B.
    CEPHALALGIA, 2009, 29 : 61 - 61
  • [36] Acute treatment optimization for migraine: results of the American migraine prevalence and prevention (AMPP) study
    Lipton, R. B.
    Manack, A. N.
    Serrano, D.
    Buse, D. C.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [37] Probable migraine in the United States: Results of the American Migraine Prevalence and Prevention (AMPP) Study
    Silberstein, S.
    Loder, E.
    Diamond, S.
    Reed, M. L.
    Bigal, M. E.
    Lipton, R. B.
    CEPHALALGIA, 2007, 27 (03) : 220 - 229
  • [38] Acute treatment optimization for migraine: results of the American migraine prevalence and prevention (AMPP) study
    RB Lipton
    AN Manack
    D Serrano
    DC Buse
    The Journal of Headache and Pain, 2013, 14
  • [39] Sex Differences in the Prevalence, Symptoms, and Associated Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study
    Buse, Dawn C.
    Loder, Elizabeth W.
    Gorman, Jennifer A.
    Stewart, Walter F.
    Reed, Michael L.
    Fanning, Kristina M.
    Serrano, Daniel
    Lipton, Richard B.
    HEADACHE, 2013, 53 (08): : 1278 - 1299
  • [40] Predictors of headache impact (HIT-6) by migraine status: results from the american migraine prevalence and prevention (AMPP) study
    Lipton, R. B.
    Manack, A.
    Serrano, D.
    Varon, S.
    Turkel, C. C.
    Buse, D. C.
    JOURNAL OF HEADACHE AND PAIN, 2010, 11 : S27 - S28
12345